trial · primary record
KITE-753
Relapsed or Refractory Large B-cell Lymphoma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 550 |
| Primary completion | 2031-05 |
| Primary endpoint | Proportion of Participants in Complete Response (CR) at Month 6 |
| Registry ID | NCT07479797 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:35.507Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07479797
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.